CNTO 6785
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CNTO 6785, covering 2013-01-28 to 2016-03-02. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 2]